Roza Derkacz

Broniewskiego 24 Str
Szczecin, ZP 70460, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Evidence for Genotype-Specific Optimal Blood Lead Levels for Cancer Risk: MKI67 rs11016073 and APOB rs1367117 in a Female Prospective Cohort.

Evidence for Genotype-Specific Optimal Blood Lead Levels for Cancer Risk: MKI67 rs11016073 and APOB rs1367117 in a Female Prospective Cohort.

Journal: International journal of molecular sciences
Published: January 03, 2026

All-Cause Mortality and Cancer Risk Dependent on Blood Se Level and HRG rs10770 Genotypes on a Prospective Cohort of Women with Familial Breast Cancers.

All-Cause Mortality and Cancer Risk Dependent on Blood Se Level and HRG rs10770 Genotypes on a Prospective Cohort of Women with Familial Breast Cancers.

Journal: International journal of molecular sciences
Published: December 27, 2025

Ultra-Trace Blood Concentrations of Blood Serum Arsenic and Breast, Prostate and Colorectal Cancer Risks in the EPIC-Heidelberg Cohort.

Ultra-Trace Blood Concentrations of Blood Serum Arsenic and Breast, Prostate and Colorectal Cancer Risks in the EPIC-Heidelberg Cohort.

Journal: Cancers
Published: December 04, 2025

Serum Iodine Levels and 8-Year Survival in Patients After Kidney Cancer Diagnosis.

Serum Iodine Levels and 8-Year Survival in Patients After Kidney Cancer Diagnosis.

Journal: Cancers
Published: August 22, 2025

Blood Lead (Pb) Levels as a Possible Marker of Cancer Risk in a Prospective Cohort of Women with Non-Occupational Exposure.

Blood Lead (Pb) Levels as a Possible Marker of Cancer Risk in a Prospective Cohort of Women with Non-Occupational Exposure.

Journal: Biomedicines
Published: May 03, 2025

Blood and Serum Copper and Zinc Levels and 10-Year Survival of Patients After Kidney Cancer Diagnosis.

Blood and Serum Copper and Zinc Levels and 10-Year Survival of Patients After Kidney Cancer Diagnosis.

Journal: Nutrients
Published: February 20, 2025

Copper and Zinc Levels, Prevalence of Common Variants of Genes Involved in Their Metabolism and Psoriasis Disease.

Copper and Zinc Levels, Prevalence of Common Variants of Genes Involved in Their Metabolism and Psoriasis Disease.

Journal: Biomedicines
Published: January 30, 2025

The Effect of Blood Selenium Level on the pCR Rate in Breast Cancer Patient Receiving Neoadjuvant Chemotherapy.

The Effect of Blood Selenium Level on the pCR Rate in Breast Cancer Patient Receiving Neoadjuvant Chemotherapy.

Journal: Cancers
Published: January 27, 2025

Blood molybdenum level as a marker of cancer risk on BRCA1 carriers.

Blood molybdenum level as a marker of cancer risk on BRCA1 carriers.

Journal: Hereditary cancer in clinical practice
Published: August 01, 2024

Blood and Serum Se and Zn Levels and 10-Year Survival of Patients after a Diagnosis of Kidney Cancer.

Blood and Serum Se and Zn Levels and 10-Year Survival of Patients after a Diagnosis of Kidney Cancer.

Journal: Biomedicines
Published: June 22, 2024

Antioxidant Properties of Zinc and Copper-Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers.

Antioxidant Properties of Zinc and Copper-Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers.

Journal: Antioxidants (Basel, Switzerland)
Published: June 05, 2024

Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer Patients.

Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer Patients.

Journal: Cancers
Published: May 31, 2024
Showing 1-12 of 34

Last Updated: 09/26/2026